EntryPoint Capital’s Tourmaline Bio TRML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$223K Sell
13,966
-11,006
-44% -$176K 0.11% 426
2025
Q1
$380K Buy
+24,972
New +$380K 0.17% 201